Same Indication

Lansoprazole vs Nivolumab

Lansoprazole vs Nivolumab: Overview

This comparison examines the pharmacological differences between Lansoprazole and Nivolumab.

Mechanism of Action

Lansoprazole: Proton pump inhibitor.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Lansoprazole — 1.5 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Lansoprazole — C16H14F3N3O2S.

Molecular Weight: Lansoprazole — 369.3620 g/mol.

Type: Lansoprazole — Small molecule; Nivolumab — Antibody.